[1]李华水,谢文焌,林强,等.桥本氏甲状腺炎差异基因筛选、分析及潜在治疗药物预测[J].福建医药杂志,2021,43(04):18-22.

点击复制

桥本氏甲状腺炎差异基因筛选、分析及潜在治疗药物预测()

分享到：

参考文献/References:

[1]Sinclair D．Clinical and laboratory aspects of thyroid autoantibodies[J]．Ann Clin Biochem，2006，43（Pt 3）：173-183.
[2]Zhang Y，Wang H，Pan X，et al．Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage：A systematic review and meta-analysis[J]．PLoS One，2017，12（4）：e0175708.
[3]Ferrari S M，Fallahi P，Elia G，et al．Thyroid autoimmune disorders and cancer[J]．Semin Cancer Biol，2020，64：135-146.
[4]Winther K H，Papini E，Attanasio R，et al．A 2018 European Thyroid Association Survey on the Use of Selenium Supplementation in Hashimoto's Thyroiditis[J]．Eur Thyroid J，2020，9（2）：99-105.
[5]Fagerholm S C，MacPherson M，James M J，et al．The CD11b-integrin （ITGAM） and systemic lupus erythematosus[J]．Lupus，2013，22（7）：657-663.
[6]Hom G，Graham R R，Modrek B，et al．Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX[J]．N Engl J Med，2008，358（9）：900-909.
[7]Anaya J M，Kim-Howard X，Prahalad S，et al．Evaluation of genetic association between an ITGAM non-synonymous SNP （rs1143679） and multiple autoimmune diseases[J]．Autoimmun Rev，2012，11（4）：276-280.
[8]Malesiński R，Bakunowicz-tazarczyk A，Wysocka J．The role of chemokines CCL3/MIP-1 alfa and CCL4/MIP-1 beta in pathogenesis of dry eye syndrome[J]．Klin Oczna，2008，110（7-9）：277-279.
[9]Ferrer-Francesch X，Caro P，Alcalde L，et al．One-tube-PCR technique for CCL2，CCL3，CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders[J]．J Endocrinol Invest，2006，29（4）：342-349.
[10]Rotondi M，Chiovato L．The chemokine system as a therapeutic target in autoimmune thyroid diseases：a focus on the interferon-γ inducible chemokines and their receptor[J]．Curr Pharm Des，2011，17（29）：3202-3216.
[11]Foucher E D，Blanchard S，Preisser L，et al．IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1α[J]．Eur J Immunol，2015，45（4）：1092-1102.
[12]Hutchinson J A，Riquelme P，Sawitzki B，et al．Cutting Edge：Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients[J]．J Immunol，2011，187（5）：2072-2078.
[13]Wang S，Liu Y，Zhao N，et al．IL-34 Expression Is Reduced in Hashimoto's Thyroiditis and Associated With Thyrocyte Apoptosis[J]．Front Endocrinol （Lausanne），2018，9：629.
[14]Burchill M A，Yang J，Vang K B，et al．Interleukin-2 receptor signaling in regulatory T cell development and homeostasis[J]．Immunol Lett，2007，114（1）：1-8.
[15]Kyrgios I，Fragou A，Kotanidou E P，et al．DNA methylation analysis within the IL2RA gene promoter in youth with autoimmune thyroid disease[J]．Eur J Clin Invest，2020，50（3）：e13199.
[16]Shao T，Shi W，Zheng J Y，et al．Costimulatory function of Cd58/Cd2 interaction in adaptive humoral immunity in a Zebrafish model[J]．Front Immunol，2018，9：1204.
[17]Greaves D R，Gordon S．Macrophage-specific gene expression：current paradigms and future challenges[J]．Int J Hematol，2002，76（1）：6-15.
[18]Ngoenkam J，Schamel W W，Pongcharoen S．Selected signal-ling proteins recruited to the T-cell receptor-CD3 complex[J]．Immunology，2018，153（1）：42-50.
[19]Podestà M A，Binder C，Sellberg F，et al．Siplizumab selec-tively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro[J]．Am J Transplant，2020，20（1）：88-100.
[20]Sbidian E，Chaimani A，Garcia-Doval I，et al．Systemic pharmacological treatments for chronic plaque psoriasis：a network meta-analysis[J]．Cochrane Database Syst Rev，2017，12（12）：CD011535.
[21]Hsu S H，Tsai T F．Evolution of the inclusion/exclusion criteria and primary endpoints in pivotal trials of biologics and small oral molecules for the treatment of psoriasis[J]．Expert Rev Clin Pharmacol，2020，13（3）：211-232.